Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 6/2017

08.03.2017 | Original Article – Cancer Research

Long non-coding RNA UCA1 regulates the expression of Snail2 by miR-203 to promote hepatocellular carcinoma progression

verfasst von: Ji-Nan Xiao, Ting-Hua Yan, Rui-Ming Yu, Yi Gao, Wen-Long Zeng, Sui-Wan Lu, Hua-Xing Que, Ze-Ping Liu, Jin-Hua Jiang

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Long non-coding RNA (LncRNA) urothelial carcinoma-associated 1 (UCA1) is reported to be dysregulated in hepatocellular carcinoma (HCC) progression. However, the functions of UCA1 in HCC still need further study. The aim is to detect the role of UCA1 involving in HCC cells proliferation and invasion, and epithelial–mesenchymal transition (EMT).

Methods

The quantitative real-time PCR was used to detect the UCA1 and miR-203 expression levels in 60 cases’ HCC tissues and adjacent normal tissues. Western blotting analysis was performed to detect the EMT markers E-cadherin, Vimentin and transcription factor Snail1, Snail2 expression. Luciferase reporter assay, RNA immunoprecipitation (RIP) and pull-down assays were used to evaluate whether miR-203 was a target of UCA1.

Results

Our results showed that UCA1 was markedly upregulated in HCC tissues and higher UCA1 expression in HCC was positively associated with tumor size, vascular invasion and American Joint Committee on Cancer (AJCC) stage (P < 0.05). Furthermore, gain-of-function and loss-of-function analysis showed that UCA1 knockdown inhibited HCC cells proliferation and invasion in vitro and xenograft tumour growth in vivo. Moreover, UCA1 overexpression promoted cell epithelial–mesenchymal transition (EMT) in HCC via effectively sponging to miR-203 and thereby activating the expression of transcription factor Snail2.

Conclusions

Our results identified that UCA1/miR-203/Snail2 pathway might involve in HCC progression. Inhibition of UCA1 acted as a promising therapeutic target for HCC patients.
Literatur
Zurück zum Zitat Bian Z, Jin L, Zhang J et al (2016) LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p. Sci Rep 6:23892CrossRefPubMedPubMedCentral Bian Z, Jin L, Zhang J et al (2016) LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p. Sci Rep 6:23892CrossRefPubMedPubMedCentral
Zurück zum Zitat Cheng N, Cai W, Ren S et al (2015) Long non-coding RNA UCA1 induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in EGFR-mutant non-small cell lung cancer. Oncotarget 6:23582–23593CrossRefPubMedPubMedCentral Cheng N, Cai W, Ren S et al (2015) Long non-coding RNA UCA1 induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in EGFR-mutant non-small cell lung cancer. Oncotarget 6:23582–23593CrossRefPubMedPubMedCentral
Zurück zum Zitat Dhanasekaran R, Limaye A, Cabrera R (2012) Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics. Hepat Med 4:19–37PubMedPubMedCentral Dhanasekaran R, Limaye A, Cabrera R (2012) Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics. Hepat Med 4:19–37PubMedPubMedCentral
Zurück zum Zitat Ding X, Park SI, McCauley LK et al (2013) Signaling between transforming growth factor beta (TGF-beta) and transcription factor SNAI2 represses expression of microRNA miR-203 to promote epithelial-mesenchymal transition and tumor metastasis. J Biol Chem 288:10241–10253CrossRefPubMedPubMedCentral Ding X, Park SI, McCauley LK et al (2013) Signaling between transforming growth factor beta (TGF-beta) and transcription factor SNAI2 represses expression of microRNA miR-203 to promote epithelial-mesenchymal transition and tumor metastasis. J Biol Chem 288:10241–10253CrossRefPubMedPubMedCentral
Zurück zum Zitat Ergun S, Oztuzcu S (2015) Oncocers: ceRNA-mediated cross-talk by sponging miRNAs in oncogenic pathways. Tumour Biol 36:3129–3136CrossRefPubMed Ergun S, Oztuzcu S (2015) Oncocers: ceRNA-mediated cross-talk by sponging miRNAs in oncogenic pathways. Tumour Biol 36:3129–3136CrossRefPubMed
Zurück zum Zitat Gao J, Cao R, Mu H (2015) Long non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancer. Int J Clin Exp Pathol 8:12936–12942PubMedPubMedCentral Gao J, Cao R, Mu H (2015) Long non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancer. Int J Clin Exp Pathol 8:12936–12942PubMedPubMedCentral
Zurück zum Zitat Gu Y, Chen T, Li G et al (2015) LncRNAs: emerging biomarkers in gastric cancer. Future Oncol 11:427–2441CrossRef Gu Y, Chen T, Li G et al (2015) LncRNAs: emerging biomarkers in gastric cancer. Future Oncol 11:427–2441CrossRef
Zurück zum Zitat Jiping Z, Ming F, Lixiang W et al (2013) MicroRNA-212 inhibits proliferation of gastric cancer by directly repressing retinoblastoma binding protein 2. J Cell Biochem 114:2666–2672CrossRefPubMed Jiping Z, Ming F, Lixiang W et al (2013) MicroRNA-212 inhibits proliferation of gastric cancer by directly repressing retinoblastoma binding protein 2. J Cell Biochem 114:2666–2672CrossRefPubMed
Zurück zum Zitat Lai MC, Yang Z, Zhou L et al (2012) Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol 29:1810–1816CrossRefPubMed Lai MC, Yang Z, Zhou L et al (2012) Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol 29:1810–1816CrossRefPubMed
Zurück zum Zitat Li W, Jiang G, Zhou J et al (2014a) Down-regulation of miR-140 induces EMT and promotes invasion by targeting Slug in esophageal cancer. Cell Physiol Biochem 34:1466–1476CrossRefPubMed Li W, Jiang G, Zhou J et al (2014a) Down-regulation of miR-140 induces EMT and promotes invasion by targeting Slug in esophageal cancer. Cell Physiol Biochem 34:1466–1476CrossRefPubMed
Zurück zum Zitat Li Z, Chao TC, Chang KY et al (2014b) The long noncoding RNA THRIL regulates TNFalpha expression through its interaction with hnRNPL. Proc Natl Acad Sci USA 111:1002–1007CrossRefPubMed Li Z, Chao TC, Chang KY et al (2014b) The long noncoding RNA THRIL regulates TNFalpha expression through its interaction with hnRNPL. Proc Natl Acad Sci USA 111:1002–1007CrossRefPubMed
Zurück zum Zitat Lu Z, Xiao Z, Liu F et al (2016) Long non-coding RNA HULC promotes tumor angiogenesis in liver cancer by up-regulating sphingosine kinase 1 (SPHK1). Oncotarget 7:241–254PubMed Lu Z, Xiao Z, Liu F et al (2016) Long non-coding RNA HULC promotes tumor angiogenesis in liver cancer by up-regulating sphingosine kinase 1 (SPHK1). Oncotarget 7:241–254PubMed
Zurück zum Zitat Maluccio M, Covey A (2012) Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J Clin 62:394–399CrossRefPubMed Maluccio M, Covey A (2012) Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J Clin 62:394–399CrossRefPubMed
Zurück zum Zitat Morise Z, Kawabe N, Tomishige H et al (2014) Recent advances in the surgical treatment of hepatocellular carcinoma. Front Surg 16:1–21 Morise Z, Kawabe N, Tomishige H et al (2014) Recent advances in the surgical treatment of hepatocellular carcinoma. Front Surg 16:1–21
Zurück zum Zitat Na XY, Liu ZY, Ren PP et al (2015) Long non-coding RNA UCA1 contributes to the progression of prostate cancer and regulates proliferation through KLF4-KRT6/13 signaling pathway. Int J Clin Exp Med 8:12609–12616PubMedPubMedCentral Na XY, Liu ZY, Ren PP et al (2015) Long non-coding RNA UCA1 contributes to the progression of prostate cancer and regulates proliferation through KLF4-KRT6/13 signaling pathway. Int J Clin Exp Med 8:12609–12616PubMedPubMedCentral
Zurück zum Zitat Ni B, Yu X, Guo X et al (2015) Increased urothelial cancer associated 1 is associated with tumor proliferation and metastasis and predicts poor prognosis in colorectal cancer. Int J Oncol 47:1329–1338PubMed Ni B, Yu X, Guo X et al (2015) Increased urothelial cancer associated 1 is associated with tumor proliferation and metastasis and predicts poor prognosis in colorectal cancer. Int J Oncol 47:1329–1338PubMed
Zurück zum Zitat Nie W, Ge HJ, Yang XQ et al (2016) LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p. Cancer Lett 371:99–106CrossRefPubMed Nie W, Ge HJ, Yang XQ et al (2016) LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p. Cancer Lett 371:99–106CrossRefPubMed
Zurück zum Zitat Song W, Gobe GC (2016) Understanding molecular pathways and targets of Brachyury in epithelial-mesenchymal transition (EMT) in human cancers. Curr Cancer Drug Targets 16:586–593CrossRefPubMed Song W, Gobe GC (2016) Understanding molecular pathways and targets of Brachyury in epithelial-mesenchymal transition (EMT) in human cancers. Curr Cancer Drug Targets 16:586–593CrossRefPubMed
Zurück zum Zitat Srivastava AK, Singh PK, Rath SK et al (2014) Appraisal of diagnostic ability of UCA1 as a biomarker of carcinoma of the urinary bladder. Tumour Biol 35:11435–11442CrossRefPubMed Srivastava AK, Singh PK, Rath SK et al (2014) Appraisal of diagnostic ability of UCA1 as a biomarker of carcinoma of the urinary bladder. Tumour Biol 35:11435–11442CrossRefPubMed
Zurück zum Zitat Wang F, Ying HQ, He BS et al (2015) Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget 6:7899–7917CrossRefPubMedPubMedCentral Wang F, Ying HQ, He BS et al (2015) Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget 6:7899–7917CrossRefPubMedPubMedCentral
Zurück zum Zitat Xiao C, Wu CH, Hu HZ (2016) LncRNA UCA1 promotes epithelial-mesenchymal transition (EMT) of breast cancer cells via enhancing Wnt/beta-catenin signaling pathway. Eur Rev Med Pharmacol Sci 20:2819–2824PubMed Xiao C, Wu CH, Hu HZ (2016) LncRNA UCA1 promotes epithelial-mesenchymal transition (EMT) of breast cancer cells via enhancing Wnt/beta-catenin signaling pathway. Eur Rev Med Pharmacol Sci 20:2819–2824PubMed
Zurück zum Zitat Xue M, Pang H, Li X et al (2016) Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway. Cancer Sci 107:18–27CrossRefPubMed Xue M, Pang H, Li X et al (2016) Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway. Cancer Sci 107:18–27CrossRefPubMed
Zurück zum Zitat Yang T, Chen M, Sun T (2013) Simvastatin attenuates TGF-beta1-induced epithelial-mesenchymal transition in human alveolar epithelial cells. Cell Physiol Biochem 31:863–874CrossRefPubMed Yang T, Chen M, Sun T (2013) Simvastatin attenuates TGF-beta1-induced epithelial-mesenchymal transition in human alveolar epithelial cells. Cell Physiol Biochem 31:863–874CrossRefPubMed
Zurück zum Zitat Yuan JH, Yang F, Wang F et al (2014) A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell 25:666–681CrossRefPubMed Yuan JH, Yang F, Wang F et al (2014) A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell 25:666–681CrossRefPubMed
Zurück zum Zitat Zhang L, Cao X, Zhang L et al (2016) UCA1 overexpression predicts clinical outcome of patients with ovarian cancer receiving adjuvant chemotherapy. Cancer Chemother Pharmacol 77:629–634CrossRefPubMed Zhang L, Cao X, Zhang L et al (2016) UCA1 overexpression predicts clinical outcome of patients with ovarian cancer receiving adjuvant chemotherapy. Cancer Chemother Pharmacol 77:629–634CrossRefPubMed
Metadaten
Titel
Long non-coding RNA UCA1 regulates the expression of Snail2 by miR-203 to promote hepatocellular carcinoma progression
verfasst von
Ji-Nan Xiao
Ting-Hua Yan
Rui-Ming Yu
Yi Gao
Wen-Long Zeng
Sui-Wan Lu
Hua-Xing Que
Ze-Ping Liu
Jin-Hua Jiang
Publikationsdatum
08.03.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 6/2017
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-017-2370-1

Weitere Artikel der Ausgabe 6/2017

Journal of Cancer Research and Clinical Oncology 6/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.